Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Joseph H. Golec"'
Publikováno v:
Journal of Financial and Quantitative Analysis. 56:915-944
We study the capital structure changes of drug firms after an investment-opportunity shock brought about by the Biologics Price Competition and Innovation Act. Using a difference-in-difference approach, we show that the shock led drug firms to make t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd09e942a2bb242d8bc387e31307e79c
https://doi.org/10.1017/s0022109020000095
https://doi.org/10.1017/s0022109020000095
Autor:
Joseph H. Golec, James C. Cooper
Publikováno v:
The Journal of Law and Economics. 62:321-346
Governments and firms often use committees of experts to help them make complex decisions, but conflicts of interest could bias experts’ recommendations. We focus on whether financial ties...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93543135161eec30e076762b4f7e064a
https://doi.org/10.1086/703206
https://doi.org/10.1086/703206
Publikováno v:
SSRN Electronic Journal.
The Food and Drug Administration uses committees of experts to evaluate potential new drugs. Weeks before they meet, the experts receive nonpublic reports from drug firms and FDA staff. We find significant abnormal options trading before meeting date
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b80a78886a89dec134cbdfdb17d5aa8b
https://doi.org/10.2139/ssrn.3825062
https://doi.org/10.2139/ssrn.3825062
Autor:
Joseph H. Golec, Joseph P. Cook
Publikováno v:
Health Economics. 26:1813-1825
Payers often assess the benefits of new drugs relative to costs for reimbursement purposes, but they frequently exclude some drugs' option-related benefits, reducing their reimbursement chances, and making them less attractive R&D investments. We dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c96b13d85668302b06a607844405199d
https://doi.org/10.1002/hec.3507
https://doi.org/10.1002/hec.3507
Autor:
James C. Cooper, Joseph H. Golec
Publikováno v:
SSRN Electronic Journal.
To evaluate some complex drugs, the Food and Drug Administration (FDA) creates committees of experts who recommend whether the drugs should be approved or rejected. The popular press and earlier studies commonly report that the FDA almost never overr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1049bb51b992ff7f30121ed7b82cd6d
https://doi.org/10.2139/ssrn.3423007
https://doi.org/10.2139/ssrn.3423007
Publikováno v:
Financial Management. 46:89-128
Mandatory pension contributions (MCs) are negative shocks to a firm's liquidity that can unfavorably impact its cost of capital, financing, and investment plans. We examine whether firms faced with MCs use both noncash (NEM) and cash-generating earni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e780f4ba6bb6d3c0cc561de6c065bda1
https://doi.org/10.1111/fima.12139
https://doi.org/10.1111/fima.12139
Autor:
Paul Borochin, Joseph H. Golec
Publikováno v:
Journal of Financial Economics. 120:169-193
Many event studies only measure a fraction of an event's full value effect because they do not adjust for market anticipation of the event. We present a method based on stock and options prices to measure the full effect that accounts for market anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f4803870dadab42be1b7debe2703f40
https://doi.org/10.1016/j.jfineco.2016.01.009
https://doi.org/10.1016/j.jfineco.2016.01.009
Autor:
James C. Cooper, Joseph H. Golec
Publikováno v:
SSRN Electronic Journal.
Governments and firms often use committees of experts to help them make complex decisions, but conflicts of interest could bias experts’ recommendations. We focus on whether financial ties to drug companies bias FDA drug advisory committee (AC) mem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6486b5643a1fa8f4a77c50488446ac21
https://doi.org/10.2139/ssrn.2944751
https://doi.org/10.2139/ssrn.2944751
Autor:
Neeraj J. Gupta, Joseph H. Golec
Publikováno v:
The Quarterly Review of Economics and Finance. 54:513-520
This paper develops a simple model of investment by service firms in intangible customer assets, and tests whether the model identifies some critical drivers of firms’ stock returns. Similar to firms with significant research and development (R&D)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef498e80fdb074f1c884370955d1d471
https://doi.org/10.1016/j.qref.2014.06.002
https://doi.org/10.1016/j.qref.2014.06.002
Publikováno v:
Real Estate Economics. 42:578-605
We study whether real estate assets have a greater positive influence on firm leverage than other tangible assets. Using a large sample of COMPUSTAT firms, we find a significant positive relation between tangibility and leverage in general, and the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f612356963bd3f08b793a798461031c4
https://doi.org/10.1111/1540-6229.12034
https://doi.org/10.1111/1540-6229.12034